Yeste-Velasco Marc, Folch Jaume, Pallàs Mercè, Camins Antoni
Unitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Institut de Biomedicina (IBUB), Centros de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Universitat de Barcelona, Avinguda Diagonal 643, 08028 Barcelona, Spain.
Neurochem Int. 2009 Feb;54(2):99-105. doi: 10.1016/j.neuint.2008.10.004. Epub 2008 Oct 21.
We investigated the role of SB202190, a selective p38 mitogen-activated protein kinase (MAPK) inhibitor in cerebellar granule neurons (CGC) in response to serum potassium deprivation (S/K deprivation), an apoptotic stimulus. CGC apoptosis after S/K deprivation was shown to be mediated through cell cycle re-entry and the induction of transcription factor E2F-1. We found that SB 202190 (10muM) inhibits retinoblastoma protein (pRb) phosphorylation, in response to S/K deprivation. Moreover, the expression of cyclin E and E2F-1 were also significantly decreased. Interestingly, SB202190 did not affect or modulate the increase in the protein expression levels of cyclin D1. Similarly, p-Akt and p-GSK3 protein levels, measured after 12h S/K deprivation, did not appear to be regulated by SB 202190 (10muM). These data indicate that the neuroprotective effects of the p38 inhibitor were not mediated via Akt activation. In conclusion, these results suggest that p38MAPK converged with the cell cycle in S/K deprivation-induced apoptosis through pRb phosphorylation.
我们研究了选择性p38丝裂原活化蛋白激酶(MAPK)抑制剂SB202190在小脑颗粒神经元(CGC)中对血清钾剥夺(S/K剥夺)这一凋亡刺激的反应中的作用。S/K剥夺后CGC凋亡被证明是通过细胞周期重新进入和转录因子E2F-1的诱导介导的。我们发现,SB 202190(10μM)可抑制S/K剥夺反应中视网膜母细胞瘤蛋白(pRb)的磷酸化。此外,细胞周期蛋白E和E2F-1的表达也显著降低。有趣的是,SB202190并不影响或调节细胞周期蛋白D1蛋白表达水平的增加。同样,在S/K剥夺12小时后测量的p-Akt和p-GSK3蛋白水平似乎不受SB 202190(10μM)的调节。这些数据表明,p38抑制剂的神经保护作用不是通过Akt激活介导的。总之,这些结果表明,在S/K剥夺诱导的凋亡中,p38MAPK通过pRb磷酸化与细胞周期汇聚。